Angioedema in renal transplant recipients on sirolimus

Dermatology

Volumn 214, Issue 3, 2007, Pages 205-209

  Mahé, Emmanuel ^a,b   Morelon, Emmanuel ^a,c   Lechaton, Sophie ^a   Kreis, Henri ^a   De Prost, Yves ^a   Bodemer, Christine ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Angioedema; Renal transplantation; Sirolimus

Indexed keywords

CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; RAPAMYCIN; TACROLIMUS;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOOD ALLERGY; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUCOSA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; URTICARIA;

ANGIONEUROTIC EDEMA; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SIROLIMUS;

EID: 33947398454     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099584     Document Type: Article

References (28)

1. Agostoni A, Cicardi M: Drug-induced angioedema without urticaria. Drug Saf 2001;24:599-606.
2. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992;117:234-242.
3. Abbosh J, Anderson JA, Levine AB, Kupin WL: Angiotensin-converting enzyme inhibitor-induced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol 1999;82:473-476.
4. Wadei H, Gruber SA, El-Amm JM, Garnick J, West MS, Granger DK, Sillix DH, Migdal SD, Haririan A: Sirolimus-induced angioedema. Am J Transplant 2004;4:1002-1005.
5. Lykavieris P, Frauger E, Habes D, Bernard O, Debray D: Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. Transplantation 2003;75:152-155.
6. Burdese M, Rossetti M, Guarena C, Consiglio V, Mezza E, Soragna G, Gai M, Segoloni GP, Piccoli GB: Sirolimus and ACE-inhibitors: a note of caution. Transplantation 2005;79:251-252.
7. Stallone G, Infante B, Di Paolo S, Schena A, Grandaliano G, Gesualdo L, Schena F: Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients. Nephrol Dial Transplant 2004;19:2906-2908.
8. Fuchs U, Zitterman A, Berthold HK, Tenderich G, Deyerling KW, Minami K, Koerfer R: Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema. Transplantation 2005;79:981-983.
9. Montalbano M, Neff GW, Yamashiki N, Meyer D, Bettiol M, Slapak-Green G, Ruiz P, Manten E, Safdar K, O'Brien C, Tzakis AG: A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications: Transplantation 2004;78:264-268.
10. Saunders RN, Metcalfe MS, Nicholson ML: Rapamycin in transplantation: a review of the evidence. Kidney Int 2001;59:3-16.
11. Kahan BD: Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 2000;356:194-202.
12. MacDonald AS; Rapamune Global Study Group: A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Trans plantation 2001;71:271-280.
13. Van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L: A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 2003;75:1934-1939.
14. Morelon E, Kreis H: Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 2003;35:S52-S57.
15. MacDonald AS: Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. Transplant Proc 2003;35:S201-S208.
16. Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF; Rapamune Maintenance Regimen Trial: Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 2004;15:809-817.
17. Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wrammer L, Brattstrom C, Charpentier B: Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999;67:1036-1042.
18. Mahé E, Morelon E, Lechaton S, Le Quan Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C: Cutaneous adverse events in renal transplant recipients on sirolimus-based therapy. Transplantation 2005;79:476-482.
19. Kunzle N, Venetz JP, Pascual M, Panizzon RG, Laffite E: Sirolimus-induced acneiform eruption. Dermatology 2005;211:366-369.
20. Laffite E, Saurat JH: Kinase inhibitor-induced pustules. Dermatology 2005;211:305-306.
21. Van Gelder T, ter Meulen CG, Hene R, Weimar W, Hoitsma A: Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 2003;75:788-791.
22. Krikorian RK, Quick A, Tal A: Angioedema following the intravenous administration of metoprolol. Chest 1994;106:1922-1923.
23. Gainer JV, Nadeau JH, Ryder D, Brown NJ: Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 1996;98:283-287.
24. Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, Fukui T, Bates DW: An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004;10:499-509.
25. Flockhart DA, Tanus-Santos JE: Implications of cytochrome P450 interactions when prescribing medication for hypertension. Arch Intern Med 2002;162:405-412.
26. Lemahieu WP, Maes BD, Verbeke K, Vanrenterghem Y: CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs tacrolimus vs sirolimus. Am J Transplant 2004;4:1514-1522.
27. Barshes NR, Goodpastor SE, Goss JA: Sirolimus-atorvastatin drug interaction in the pancreatic islet transplant recipient. Transplantation 2003;76:1649-1650.
28. Jeanmart H, Malo O, Carrier M, Nickner C, Desjardins N, Perrault LP: Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. J Heart Lung Transplant 2002;21:990-998.